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Purpose: For the atypical cases of fine needle aspiration (FNA) cytology of thyroid nodules, ultrasonographic findings are a 
primary guideline for the surgical treatment. However, they have the intrinsic risk of overtreatment, as well. In this study we 
examined whether the Bethesda system could provide a real effect on the diagnostic rate of atypical cytology, and thereby re-
duce the number of cases diagnosed as atypical from FNA cytology. Methods: We reviewed 166 cases diagnosed as atypical 
by FNA cytology at this institute between the years 2005 to 2010. We classified these cases on the basis of ultrasonographic 
and cytological findings and compared them with the histological results. Results: Ultrasonographically, findings suspicious 
for malignancy and indeterminate were associated with 83.7% and 47.2% of malignancy rates, respectively. Cytopathologi-
cally, the malignancy rates varied according to the main cytological features and the highest malignancy rate was 77.3%. 
Based on the Bethesda system, 39.2% of the cases diagnosed as atypical could be grouped into the category of suspicious for 
malignancy and yielded a malignancy rate of 76.9%. Conclusion: Although ultrasonography provides an excellent guideline 
for the surgical treatment of atypical cases, it also showed considerable risk of overtreatment. The Bethesda system did not 
offer definitive effects on the rate of atypical cytology, but this system seemed to provide stricter boundaries for the atypical 
cytology and to aid in reducing the rates thereof. This in turn may permit that more limited cases are allotted to ultrasono-
graphic decision making.
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INTRODUCTION
Fine needle aspiration (FNA) cytology is one of the most 
important and reliable diagnostic methods in the evalua-
tion of thyroid nodules [1,2]. Although FNA cytology is al-
so an important diagnostic method for the identification of 
follicular lesions based on which follicular carcinoma 
could be selected for surgical treatment [3-5], the screen-
ing for papillary carcinoma is generally considered to be 
the most important area. Therefore, it may be correctly 
stated that the most important role of FNA cytology of the 
thyroid nodule is the selection of cases of papillary Yoo Seung Chung, et al.
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carcinoma. 
When planning the surgical treatment for the thyroid 
nodule, the clinical information including ultrasonogra-
phic findings such as configuration and size of the lesions 
become the primary guideline. FNA cytology is carried 
out under the guidance of ultrasound. When the cytologic 
results are either benign or malignant, or at least suspi-
cious for malignancy, the treatment will be decided based 
on these results. But when the cytological diagnosis is re-
ported as atypical only, clinicians could be confronted 
with some difficulties in the management of patients. 
There have been many instances in which inevitably a di-
agnosis of atypical cytology was made, but when we re-
viewed these cases which had been previously diagnosed 
as atypical, the maximum number of cases showed the 
characteristic cytological features of papillary carcinoma 
but displayed low cellularity. Although the diagnosis of 
atypical cytology reflects the difficulties in cytological in-
terpretation, it is also evident that when the diagnosis rate 
of atypical cytology will be as low as possible, the treat-
ment plan will be more easily established.     
The diagnosis rates of atypical cytology vary among dif-
ferent institutions. At our institute, from the year 2005 to 
2010 the diagnosis rate of atypical cytology was approx-
imately 13%. Recently, the Bethesda system defined the di-
agnostic categories and provided the diagnostic criteria 
for each category [6,7]. It is likely that this system raised an 
alert on the random allocation of many cytological cases 
into the atypical category. 
In the clinical aspect, when the cytological results were 
atypical, surgical treatments of the thyroid nodules are de-
termined on the basis of ultrasonographic findings. But 
the ultrasonographic guideline also contains the risk of 
overtreatment. If the diagnostic rate of atypical cytology is 
reduced as possible, more cases may have definite cyto-
logical basis for the surgical treatment, and more limited 
cases will be allotted to the ultrasonographic decision. In 
this study we aimed to know whether the Bethesda system 
could provide real effect on the diagnostic rate of atypical, 
and thereby it could make influential effect on the overall 
histological outcome including atypical cases in which de-
cision making for the surgical treatment is done according 
to the ultrasonographic findings. Therefore, this study 
was planned on two aspects. First, we estimate the in-
trinsic risk of ultrasonogram on the basis of malignancy 
rate for the cases of atypical cytology. Second, we re-
viewed the cases of atypical cytology on the basis of the 
Bethesda system to know whether the diagnosis rate of 
atypical cytology could be reduced when the diagnostic 
criteria which this system provides were applied in the in-
terpretation of FNA cytology.
METHODS
Materials 
Among 3,962 cases of FNA cytology of the thyroid nod-
ules which performed in this institute from 2005 to 2010, 
515 cases (13%) were diagnosed as atypical. From them, 
166 cases were selected for this study. The eligibility cri-
teria were as follows: 1) The case was diagnosed as atyp-
ical; 2) There were no comments such as suspicious for ma-
lignancy or the possibility of malignancy cannot be ruled 
out etc; 3) The histological diagnosis was made after surgi-
cal treatment; 4) On slide reviews if there was a sufficient 
cellular yield based on which the diagnosis of papillary 
carcinoma or nodular hyperplasia could be made, then 
such cases were excluded. This study was approved by the 
Clinical Study Medical Ethics Committee (VC10TISI0138).
Methods
In this study, we made an analysis of the cases on two 
as p e c ts .  F ir s tl y ,  on  th e  c l i n ic al  as p e c t w e  a rr a n g e d th e  
guideline for the surgical treatments of patients with thy-
roid nodules and compared their histological results after 
surgery. Then on the pathological aspect we made an anal-
ysis of the atypical cases on the basis of main cytological 
features and their histological results, and then we made 
an analysis of these cytological features according to the 
Bethesda system. 
Guideline for the surgical treatment of thyroid 
nodules 
At our institute in the department of surgery, the deci-
sions for the surgical treatment of thyroid nodules were 
primarily based on the results of FNA cytology and ultra-Atypical cytology and the Bethesda system
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Fig. 1. Schematic presentation of guidelines for treatment of thyroid nodules. FNA, fine needle aspiration; USG, ultrasonographic.
sonographic findings. When a diagnosis of papillary carci-
noma or other malignancies such as medullary carcinoma 
was made on FNA cytology, surgery was performed re-
gardless of the ultrasonographic findings. When the cyto-
logical findings were suggestive of benign lesions such as 
nodular hyperplasia, the modalities of treatment were de-
cided on the basis of size of the lesions estimated by ultra-
sonography and the present symptomatology. When fol-
licular neoplasm was suspected and the tumor size ex-
ceeded 2.0 cm on ultrasonography, surgery was recom-
mended. When the cytological diagnoses were atypical, 
ultrasonographic findings were the primary guideline. In 
ultrasonogram, category of suspicious for malignancy 
was made when one of the following findings are noted: 
speculated border, taller than wide configuration, marked 
hypoechogenic texture or calcification. When purely cyst-
ic lesion or colloidal nodules were noted, the inter-
pretation was made as benign. Other cases were inter-
pretated as indeterminate [8]. The surgical treatment was 
performed in all atypical cases with ultrasonographic 
findings of suspicious for malignancy and indeterminate. 
In cases of suspicious for malignancy, total thyroidectomy 
was performed if the nodular size was more than 1.0 cm, 
but lobectomy was performed if the nodular size was less 
than 1.0 cm. In some exceptional cases with the nodular 
size same as earlier, lobectomy was performed when the 
patient requested for it and when there was no evidence of 
lesions in the other lobe. Even in case when the nodular 
size was less than 1.0 cm total thyroidectomy was per-
formed, when surgical treatment was required for lesions 
in the contralateral lobe, when metastatic lymphadenop-
athy was suspected in the neck, or when the patient re-
quested for total thyroidectomy. In cases with indetermin-
ate findings, lobectomy was performed regardless of the 
nodular size. When an indeterminate nodule or a sympto-
matic benign nodule was found in the contralateral lobe, 
total thyroidectomy was performed. When the ultrasono-
graphic finding was reported as benign, surgery was per-
formed only if the patient requested for it (Fig. 1). 
Classification of the cytological findings of atyp-
ical cases and matching these findings with the 
histological results 
At this institute, cytological interpretations were done 
in the following categories: unsatisfactory, benign, atyp-
ical, malignancy and others. The benign category included 
nodular hyperplasia, Hashimoto’s thyroiditis and so on. 
When there were various cellular features including nu-Yoo Seung Chung, et al.
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Our institute’s system The Bethesda system
I. Adequacy of specimen
  1. Satisfactory for evaluation
  2. Unsatisfactory for evaluation
II. Cytologic diagnosis
  1. Negative for malignancy
  2. Atypical cells
  3. Malignancy
  4. Others 
I. Nondiagnostic or unsatisfactory
II. Benign
III. Atypia of undetermined significance or follicular lesion of undetermined significance
IV. Follicular neoplasm or suspicious for  follicular neoplasm
V. Suspicious for malignancy
VI. Malignancy
Table 1. Comparison of diagnostic schemes
clear features suggestive of papillary carcinoma, but they 
were inadequate for making the diagnosis of malignancy, 
the atypical category was applied. The malignancy cat-
egory was applied when overt malignant features were 
found in the specimen. The category of others included 
various conditions including follicular neoplasms (Table 
1). Among these categories, we reviewed the slides and cy-
tological reports of the 166 atypical cases and classified 
them according to the representative cytological features. 
After that we again classified these features according to 
the Bethesda system, and these findings were then match-
ed with the histological results. The slide review was done 
by a single pathologist. Cytological slides were made by 
the conventional method.   
The Bethesda system for reporting thyroid cytopa-
thology
Generally, when the diagnosis is atypical, one may bear 
in mind the likelihood of papillary carcinoma. So, it may 
be the ideal method when cases suspicious for malignancy 
can be selected from these atypical cases with more strin-
gent criteria. The diagnostic scheme of the Bethesda sys-
tem is depicted in Table 1. In the Bethesda system some 
specific criteria are applied to each diagnostic category. In 
this study, we focused on the criteria for the categories of 
atypical cells of undetermined significance (AUS) and sus-
picious for malignancy [6,7,9].
Diagnostic criteria for the category of AUS
In the Bethesda system, diagnosis of AUS is recom-
mended when the following cytological findings are not-
ed: population of microfollicles that does not fulfill the cri-
teria for follicular neoplasm, predominance of Hurthle 
cells in the low cellular smear or in the benign-appearing 
sample, several artifacts, focal features suggestive of pap-
illary carcinoma in an otherwise predominantly benign- 
appearing sample, cyst-lining cells, minor population of 
nuclear abnormalities, and atypical lymphoid infiltrates.  
Diagnostic criteria for the category of suspicious for papillary 
carcinoma
In the Bethesda system this category is divided into four 
groups. Pattern A (patchy nuclear changes pattern) con-
sists of predominantly benign follicular cells with foci of 
atypical cells having nuclear enlargement, nuclear groove 
and so on. Intranuclear pseudoinclusion is infrequent. 
Pattern B (incomplete nuclear changes pattern) is charac-
terized by mild to moderate nuclear enlargement with nu-
clear groove in the majority of cells and with varied 
cellularity. Similar to pattern A, intranuclear pseudoinclu-
sion is infrequent in pattern B. Pattern C (sparsely cellular 
specimen pattern) is characterized by nuclear features of 
papillary carcinoma but with very low cellularity. Pattern 
D (cystic degeneration pattern) is characterized by evi-
dence of cystic change with various nuclear abnormalities. 
Psammoma bodies are also found in this pattern.   
In this study, the representative cytological features 
were reclassified according to the features included in the 
categories of AUS and suspicious for papillary carcinoma 
of the Bethesda system. 
RESULTS 
General characteristics
Among the 166 atypical cases, 16 were men (9.7%) and Atypical cytology and the Bethesda system
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Gender
Histological results 
Papillary 
carcinoma
Nodular
 hyperplasia
Follicular 
neoplasia
a)
Hashimoto’s 
thyroiditis
Granulomatous 
thyroiditis
Total
Female 100 (60.2) 36 (21.7) 7 (4.2) 6 (3.6) 1 (0.6) 150 (90.4)
Male   9 (5.4) 4 (2.4) 2 (1.2) 1 (0.6) 0 (0.0) 16 (9.6)
Total 109 (65.7) 40 (24.1) 9 (5.4) 7 (4.2) 1 (0.6)  166 (100.0)
Values are presented as number (%).
a)Follicular neoplasia included follicular adenoma, Hurthle cell adenoma and follicular carcinoma.
Table 2. General characteristics and histological results of current atypical cases
Findings on 
ultrasonogram (No.)
Tumor size on 
ultrasonogram (No.)
Operation type (No.) Histology  (No.)
Rate of 
malignancy 
(%)
SM 92 ≤1.0 cm 62 L 47 M 41 85.48
B6
TT 15 M 12
B3
＞1.0 cm 30 L 6 M 4 80.00
B2
TT 24 M 20
B4
I 72 ≤1.0 cm 35 L 26 M 14 62.85
B1 2
TT 9 M 8
B1
＞1.0 cm 37 L 17 M 6 32.43
B1 1
TT 20 M 6
B1 4
B 2 ≤1.0 cm 1 L 1 M 0 0.00
B1
TT 0 M 0
B0
＞1.0 cm 1 L 1 M 1 100.00
B0
TT 0 M 0
B0
SM, suspicious for malignancy; I, indeterminate; B, benign; L, lobectomy; TT, total thyroidectomy; M, malignancy; B, benign.
Table 3. Ultrasonographic findings and surgical results of cases of atypical cytology
150 were women (90.3%). With histological examination, 
the most frequently diagnosed were papillary carcinomas 
(65.7%), and nodular hyperplasia was diagnosed in 24.1% 
of the cases. Other diagnoses included follicular neo-
plasms, Hashimoto’s thyroiditis and granulomatous thy-
roiditis (Table 2).
Ultrasonographic findings and surgical results
Among 166 cases, 92 cases were diagnosed as suspi-
cious for malignancy and 72 cases were diagnosed as in-
determinate ultrasonographically. The remaining 2 cases 
were diagnosed as benign, but after surgery one case was 
confirmed as Hurthle cell adenoma and the other as papil-
lary carcinoma. In cases suspicious for malignancy, 83.69% 
(77/92) were papillary carcinoma histologically. In these 
cases, 85.48% (53/62) were diagnosed as papillary carcino-
ma when the nodular size was less than 1.0 cm, and 80.0% 
(24/30) were diagnosed as papillary carcinoma when the Yoo Seung Chung, et al.
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Cytological features No. (%)
Surgical diagnosis, No. (%)
a)
Rate of 
malignancy (%)
PC NH FN HT GT
Nuclear grooves with or without 
pseudoinclusions
  66 (39.8)    51 (77.3) 12 (18.2) 1 (1.5) 2 (3.0) 0 (0.0) 77.3
Suspicious nuclear grooves   61 (36.7)   37 (60.7) 18 (29.5) 4 (6.6) 2 (3.3) 0 (0.0) 60.7
HCC with suspicious nuclear abnormalities 
such as nuclear grooves or enlarged nucleus
12 (7.2)    7 (58.3)  3 (25.0) 1 (8.3) 1 (8.3) 0 (0.0) 58.3
HCC without nuclear abnormalities 4 (2.4)    2 (50.0)  1 (25.0) 1 (25.0) 0 (0.0) 0 (0.0) 50.0
Other features such as enlarged nuclei, 
prominent nucleoli, psammoma bodies, 
papillary fronds, etc.
19 (11.4)  11 (57.9)  4 (21.1) 1 (5.3)  2 (10.5) 1 (5.3) 57.9
Microfollicles with mild nuclear atypism  4 (2.4)    1 (25.0)  2 (50.0)  1 (25.0) 0 (0.0) 0 (0.0) 25.0
Total  166 (100.0) 109 (65.7) 40 (24.1) 9 (5.4) 7 (4.2) 1 (0.6)
PC, papillary carcinoma; NH, nodular hyperplasia; FN, follicular neoplasm; HT, Hashimoto’s thyroiditis; GT, granulomatous thyroiditis.
a)This indicates the percentage within a surgical diagnosis.
Table 4. Frequencies of cytological features in cases of atypical cytology
nodular size was more than 1.0 cm. The remaining 15 cases 
were diagnosed as benign lesions including nodular hy-
perplasia, follicular adenoma, Hurthle cell adenoma, 
Hashimoto’s thyroiditis and granulomatous thyroiditis. 
In cases of the indeterminate group, 47.22% (34/72) were 
found to be histologically malignant including one case of 
follicular carcinoma and two cases of Hurthle cell 
carcinoma. The remaining majority of cases were of papil-
lary carcinoma. Among these 34 cases, 62.85% (22/35) were 
diagnosed as malignant when the nodular size was less 
than 1.0 cm. 32.43% (12/37) were diagnosed as malignant 
when the nodular size was more than 1.0 cm. The remain-
ing cases were diagnosed as benign lesions (Table 3). 
Representative cytological features and their histo-
logical results 
Among the cytological features found in the atypical 
cases, the most frequent finding was the infrequent nu-
clear grooves and intranuclear pseudoinclusions in scant 
cellularity (66/166; 39.8%), and these cases were histologi-
cally confirmed as papillary carcinoma in 77.3% (51/66) of 
the cases. The second most frequent finding was the suspi-
cious nuclear groove (61/166; 36.7%), and 60.7% (37/61) of 
these cases were histologically confirmed as papillary 
carcinoma. Other findings included Hurthle cell change, 
papillary fronds, psammoma bodies and microfollicles, 
and these findings were associated with papillary carcino-
ma in varying proportions (Table 4, Fig. 2).
Reclassification according to the Bethesda system 
and their histological results 
Representative cytological findings of atypical cases 
were classified according to the criteria for AUS and suspi-
cious for malignancy categories. Among the features pre-
sented in Table 4, features of nuclear grooves and intra-
nuclear pseudoinclusions were allocated to pattern C of 
the suspicious for malignancy category. Other allocations 
are presented in Table 5. Since the cytological features of 
nuclear grooves and intranuclear pseudoinclusions are in-
cluded in the category of suspicious for malignancy ac-
cording to the Bethesda system, 65 (39.2%) of the 166 atyp-
ical cases were included into the category of suspicious for 
malignancy, and 50 (76.9%) of these 65 cases were histolog-
ically confirmed as papillary carcinoma. Seventy-three 
(44.0%) of the 166 atypical cases showed focal nuclear ab-
normalities and 44 (60.3%) of these 73 cases were histologi-
cally confirmed as papillary carcinoma. 
DISCUSSION  
Generally, thyroid nodules are found in 4 to 10% of the 
adults, and their incidence has been on a rise when ultra-
sonographic examination is carried out [4,10]. When thyroid Atypical cytology and the Bethesda system
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Fig. 2. (A) Nuclear grooves or pseudoinclusions are significant cytological features strongly suggestive of papillary carcinoma. In these cases, 
papillary carcinoma could be safely diagnosed inspite of low cellularity. (B) In this case, a suspicious nuclear groove is noted in a few follicular 
cells, but when most of the sample appears benign, it would be more appropriate to diagnose this as a benign lesion. The histological diagnosis
was nodular hyperplasia. (C) In this case diagnosed as nodular hyperplasia after surgery, the cytological features show low cellularity, but 
also show suspicious nuclear pseudoinclusions (arrow) and irregularity, hence atypical cells of undetermined significance (AUS) is the 
proper diagnosis. (D) In this case, Hurthle cell changes in the follicular epithelial cells are noted, but suspicious nuclear grooves are also 
present and hence AUS is the proper diagnosis. The histological diagnosis was papillary carcinoma. (E) If Hurthle cell changes are 
accompanied with a microfollicular pattern, then the diagnosis of follicular neoplasm should be kept in mind. (F) Even though the typical 
nuclear features of papillary carcinoma are not distinctive, the presence of papillary fronds, enlarged nuclei or psammoma bodies could be 
associated with papillary carcinoma. So in these cases, a diagnosis of AUS should be made (Papanicolaou stain, ×400; inlet, ×1,000).
Categories and diagnostic criteria No. (%)
Surgical diagnosis, No. (%)
a)
Rate of 
malignancy (%) PC NH FN HT GT
Atypia of undetermined significance
Microfollicles 4 (2.4)  2 (50.0)  1 (25.0)  1 (25.0) 0 (0.0) 0 (0.0)  50.0
Predominant Hurthle cells 4 (2.4)  2 (50.0)  1 (25.0)  1 (25.0) 0 (0.0) 0 (0.0)  50.0
Several artifacts 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) -
Focal features suggestive of papillary 
 carcinoma
73 (44.0) 44 (60.3) 21 (28.8) 5 (6.8) 3 (4.1) 0 (0.0)  60.3
Cyst-lining cells 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) -
Other nuclear abnormalities such as 
  nuclear enlargement, prominent 
  nucleoli, etc.
19 (11.4) 11 (57.9)  4 (21.1) 1 (5.3)  2 (10.5) 1 (5.3)  57.9
Atypical lymphoid cells 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) -
Suspicious for papillary carcinoma
Pattern A 1 (0.6)    1 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 100.0
Pattern B 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) -
Pattern C 65 (39.2) 50 (76.9) 12 (18.5) 1 (1.5) 2 (3.1) 0 (0.0)  76.9
Pattern D 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) -
PC, papillary carcinoma; NH, nodular hyperplasia; FN, follicular neoplasm; HT, Hashimoto’s thyroiditis; GT, granulomatous thyroiditis.
a)This indicates the percentage within a surgical diagnosis.
Table 5. Reclassification of cytological features according to Bethesda systemYoo Seung Chung, et al.
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nodules are suspected, application of ultrasonographic 
examination and FNA cytology under the guidance of ul-
trasonography is the standard procedure [1,3]. In fact, ul-
trasonography is also important for the interpretation of 
FNA cytology because the configuration of thyroid nod-
ules identified in ultrasonography provides useful in-
formation for the interpretation of atypical cells [11,12]. 
An ideal cytologic report can be made when the patient’s 
clinical, laboratory and radiological information can be re-
ferred to before the cytological slides are examined [12]. 
When the cytologic report is reported as benign, follow-up 
is required, but in cases of malignancy or at least suspi-
cious for malignancy, surgical treatment is required. In 
cases when follicular neoplasm is suspected or in the in-
determinate cases, treatment modality can be decided ac-
cording to the circumstances. Thus, FNA cytology pro-
vides an important guideline for the treatment of thyroid 
nodules by which on one hand the risk of unnecessary sur-
gery is reduced and it also provides an appropriate oppor-
tunity for surgery of the malignant disease [12]. But, FNA 
cytology has some limitations. For example, its diagnosis 
rate is low in the case of follicular neoplasm [13].
Papillary carcinomas are the most frequent malig-
nancies occurring in the thyroid gland and constitute ap-
proximately 70 to 80% of all thyroid malignancies [5]. 
Although FNA cytology is the important diagnostic tool in 
the evaluation of thyroid nodules [5,7], screening for pap-
illary carcinoma is the most important. The diagnosis rate 
of papillary carcinoma by FNA cytology is high because 
the pathologists are relatively familiar to the cytological 
features of papillary carcinomas [5]. And ultrasonography 
is indispensible in the evaluation of thyroid nodules and 
contributes in increasing the diagnosis rate of papillary 
carcinoma [14]. Diagnostic categories vary among differ-
ent institutes, but the categories of unsatisfactory speci-
men, benign, atypical or indeterminate, suspicious for ma-
lignancy, and malignancy are representative [15,16]. The 
Bethesda system which was introduced in 2007 provided 
six diagnostic categories for standardization of the diag-
nostic terms. This system grouped follicular neoplasms in-
to an independent category, and since follicular carcinoma 
cannot be differentiated from follicular adenoma, the cate-
gories of suspicious for malignancy and malignancy in-
clude all malignancies of the thyroid gland except for fol-
licular carcinoma. This system aimed to use identical diag-
nostic terms and ensure similarity in the interpretation of 
diagnostic results by the application of criteria for each di-
agnostic category [7,9,12,17,18]. Herein, the category of 
AUS includes diverse conditions, but these conditions can 
be roughly classified into two groups which are sugges-
tive of papillary carcinoma on one hand and of follicular 
neoplasms on the other. According to the reports, the diag-
nosis rate of atypical cytology by FNA cytology of the thy-
roid nodule varies from 3% to 20% [7,19]. On histological 
studies of these atypical cases, papillary carcinoma was 
the most frequent diagnosis, and this finding is similar to 
the results of this study. The Bethesda system recom-
mends that the diagnosis rate of atypical cytology should 
be less than 7% [6,7]. In this institute, diagnosis rate of 
atypical cytology was about 13.0% and this rate seems to 
be far exceed the limit which the Bethesda system 
recommends. But we selected 166 cases for this study ac-
cording to the criteria as mentioned in the section of mate-
rial and methods, and these cases occupy about 4.0% of to-
tal FNA cytology cases. This indicates excessive cases are 
allotted in the atypical category. Actually, even though the 
characteristic nuclear features of papillary carcinomas are 
evident while the cellularity is low, there is a tendency to 
make a diagnosis as atypical only. Besides, there may be 
many conditions which can give rise to indeterminate 
findings. Also, a considerable number of cytological sme-
ars from the cases of follicular neoplasm could be in-
terpreted as simply benign lesions. Taken together, many 
cytological examinations remain ambiguous due to the 
lack of provision of precise guidelines for the clinicians. 
From the results of this study, firstly we know that 
guidelines for the surgical treatment based on the ultra-
sonographic findings could provide a considerably pre-
cise discrimination power for diagnosing papillary carci-
nomas. But there were considerable risk of overtreatment 
also. Therefore it is certain that if atypical cases reduce, 
more limited cases will confront this risk. Second, among 
these atypical cases which were diagnosed according to 
the diagnostic scheme used at this institute, the cytopatho-
logical aspect revealed that 77% of these atypical cases 
were confirmed as papillary carcinoma on histological Atypical cytology and the Bethesda system
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examination. The Bethesda system systematized the pre- 
existing cytological knowledge, but the clarification of cri-
teria for atypical cytology is worthy of special attention. 
According to this study, the nuclear features such as nu-
clear grooves with or without intranuclear pseudoinclu-
sions were confirmed to be the important findings sugges-
tive of papillary carcinoma. Hence, even when the cellu-
larity is not sufficient for establishing a definite diagnosis, 
with these cytological features we think that the category 
of suspicious for malignancy is more appropriate than just 
the atypical category. In this study 39.2% of the cases of 
atypical cytology were included in the category of suspi-
cious for malignancy and 76.9% of them were histologi-
cally confirmed as papillary carcinoma. Hurthle cell 
change can be found in the benign conditions such as 
Hashimoto’s thyroiditis and nodular hyperplasia, so the 
presence of Hurthle cell alone cannot be a reliable in-
dicator of papillary carcinoma. But when certain nuclear 
abnormalities accompany the Hurthle cell change, the cat-
egory of AUS is more appropriate [20]. Papillary fronds, 
psammoma bodies or indetermined nuclear abnormal-
ities can accompany papillary carcinoma, and so these 
findings can be the features of AUS. When mild nuclear 
atypism was found, microfollicles were sometimes diag-
nosed as atypical, but some cases were histologically diag-
nosed as nodular hyperplasia. When some cases were con-
firmed as follicular neoplasms, the category of AUS or sus-
picious for follicular neoplasms may be more appropriate. 
Conclusively, it seems probable that on the basis of the 
above results and the criteria provided in the Bethesda 
system, the diagnosis rate of atypical or AUS cases could 
be reduced and more standardized cytological reports can 
be obtained [13,21,22]. 
But on the other hand, it is uncertain as to how much 
these criteria can actually influence the cytological inter-
pretation in a real situation. In this study, many cases of 
atypical cytology were allocated to the category of suspi-
cious for malignancy logically, but it is doubtful whether 
in an actual situation the same proportion of cases will not 
be allocated to the atypical category. Even though the cyto-
logical features are evident for making a diagnosis of pap-
illary carcinoma, the pathologists still hesitate when the 
cellular yield is not sufficient. Although a clarification on 
whether the lesion is benign or malignant may be the most 
ideal, but still the diagnosis of atypical cytology is in-
evitable due to the various ambiguous situations. So, the 
most in-demand task is to reduce the diagnosis rate of 
atypical cytology to as low as possible. Ultrasonographic 
findings and atypical cytology showed a considerable dis-
crimination power for malignant diseases, but there may 
be some cases in which unnecessary surgeries have been 
performed. If we consider the fact the main role of ultra-
sonography and cytological examinations was to screen 
the malignant lesion as precisely as possible and to reduce 
the possibility of unnecessary surgery, it is certain that the 
excessive allocation of cases to the atypical category may 
result in overtreatment in some of the patients. From this 
study it is difficult to confirm that the Bethesda system can 
make a remarkable difference in the diagnostic results. But 
when the cytological interpretation is made based on ref-
erence to these criteria provided by the Bethesda system 
and ultrasonographic findings, the diagnosis rate of atyp-
ical cytology can be reduced and more assertive guide-
lines can be provided for the clinicians.  
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